Greenwich LifeSciences Inc.
GLSI | NASDAQ
$14.65
-$1.70 (-10.40%)
At close: Nov 5, 2026, 4:00 PM ET
$14.80
+$0.15 (+1.03%)
After-hours:
Nov 5, 2026, 6:00 PM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | 876 | 903 | 903 | 903 | 903 | 903 | 903 | 903 | 903 | 903 | 903 | 903 | 903 | 903 | 903 | 903 | 903 | 903 |
Gross Profit | n/a | n/a | n/a | n/a | -876 | -903 | -903 | -903 | -903 | -903 | -903 | -903 | -903 | -903 | -903 | -903 | -903 | -903 | -903 | -903 | -903 | -903 |
Operating Income | -4.02M | -5.73M | -7.94M | -4.17M | -4.05M | -2.77M | -8.08M | -2.73M | -2.66M | -2.54M | -2.84M | -2.5M | -1.75M | -2.24M | -2.89M | -2.38M | -773.31K | -1.99M | -2.38M | -866.69K | -753.45K | -600.61K |
Interest Income | 72.97K | 68.62K | 22.26K | 22.8K | 20.68K | 23.97K | 43.94K | 60.34K | 54.72K | 64.01K | 89.29K | 111.14K | 119.45K | 116.18K | 104.17K | 64.04K | 27.23K | 19.58K | 16.5K | 3.57K | 3.7K | 3.6K |
Pretax Income | -3.95M | -5.66M | -7.92M | -4.15M | -4.03M | -2.74M | -8.04M | -2.67M | -2.61M | -2.47M | -2.75M | -2.39M | -1.63M | -2.12M | -2.79M | -2.32M | -746.07K | -1.97M | -2.36M | -863.12K | -749.75K | -597.01K |
Net Income | -3.95M | -5.66M | -7.92M | -4.15M | -4.03M | -2.74M | -8.04M | -2.67M | -2.61M | -2.47M | -2.75M | -2.39M | -1.63M | -2.12M | -2.79M | -2.32M | -746.07K | -1.97M | -2.36M | -863.12K | -749.75K | -597.01K |
Selling & General & Admin | 462.93K | 518.19K | 653.07K | 653.07K | 538.05K | 496.7K | 1.93M | 437.01K | 353.53K | 341.79K | 502.15K | 344.76K | 368.26K | 412.27K | 435.68K | 658.67K | 139.15K | 327.48K | 313.3K | 209.59K | 196.91K | 318.63K |
Research & Development | 3.56M | 5.21M | 3.52M | 3.52M | 3.51M | 2.27M | 6.16M | 2.29M | 2.31M | 2.19M | 2.33M | 2.16M | 1.38M | 1.83M | 2.46M | 1.72M | 633.25K | 1.66M | 2.06M | 657.1K | 556.53K | 281.98K |
Other Expenses | n/a | 0 | 3.77M | 0 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 4.02M | 5.73M | 7.94M | 4.17M | 4.05M | 2.77M | 8.08M | 2.73M | 2.66M | 2.54M | 2.84M | 2.5M | 1.75M | 2.24M | 2.89M | 2.38M | 772.4K | 1.99M | 2.38M | 865.78K | 752.54K | 599.7K |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -903 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 4.02M | 5.73M | 7.94M | 4.17M | 4.05M | 2.77M | 8.08M | 2.73M | 2.66M | 2.54M | 2.84M | 2.5M | 1.75M | 2.24M | 2.89M | 2.38M | 773.31K | 1.99M | 2.38M | 866.69K | 753.45K | 600.61K |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 14.62M | 14.57M | 13.64M | 13.64M | 13.37M | 13.17M | 13.15M | 13.14M | 12.91M | 12.86M | 12.85M | 12.85M | 12.85M | 12.85M | 12.65M | 12.82M | 12.92M | 13.06M | 12.9M | 12.97M | 12.9M | 12.8M |
Shares Outstanding (Diluted) | 14.62M | 14.57M | 13.64M | 13.64M | 13.37M | 13.17M | 13.15M | 13.14M | 12.91M | 12.86M | 12.85M | 12.85M | 12.85M | 12.85M | 12.65M | 12.82M | 12.92M | 13.06M | 12.9M | 12.97M | 12.9M | 12.8M |
EPS (Basic) | -0.27 | -0.39 | -0.58 | -0.30 | -0.30 | -0.25 | -0.61 | -0.20 | -0.20 | -0.19 | -0.21 | -0.19 | -0.13 | -0.16 | -0.21 | -0.18 | -0.06 | -0.15 | -0.18 | -0.07 | -0.06 | -0.05 |
EPS (Diluted) | -0.27 | -0.39 | -0.58 | -0.30 | -0.30 | -0.25 | -0.61 | -0.20 | -0.20 | -0.19 | -0.21 | -0.19 | -0.13 | -0.16 | -0.21 | -0.18 | -0.06 | -0.15 | -0.18 | -0.07 | -0.06 | -0.05 |
EBITDA | -3.95M | -5.66M | -7.92M | -4.15M | -4.02M | -2.74M | -8.04M | -2.67M | -2.61M | -2.47M | -2.75M | -2.39M | -1.63M | -2.12M | -2.79M | -2.32M | -745.17K | -1.97M | -2.36M | -862.22K | -748.84K | -599.7K |
EBIT | -3.95M | -5.66M | -7.92M | -4.15M | -4.03M | -2.74M | -8.04M | -2.67M | -2.61M | -2.47M | -2.75M | -2.39M | -1.63M | -2.12M | -2.79M | -2.32M | -746.07K | -1.97M | -2.36M | -863.12K | -749.75K | -600.61K |
Depreciation & Amortization | 1.78K | n/a | n/a | n/a | 876 | 903 | 903 | 903 | 903 | 903 | 903 | 903 | 903 | 903 | 903 | 903 | 903 | 903 | 903 | 903 | 903 | 903 |
Add to Watchlist
Select watchlists to add or remove GLSI